Getting the Deal Through: Pharmaceutical Antitrust 2019
Getting the Deal Through: Pharmaceutical Antitrust 2019

The following In-House Advisor guidance note provides comprehensive and up to date legal information covering:

  • Getting the Deal Through: Pharmaceutical Antitrust 2019
  • Jurisdictions covered
  • Questions

Click here to download the latest Pharmaceutical Antitrust 2019 report, published by Getting the Deal Through.

Jurisdictions covered

The following jurisdictions are covered in this report:

Brazil; Bulgaria; Canada; China; European Union; Finland; France; Germany; India; Japan; Portugal; Romania; Spain; Turkey; United Kingdom; United States

Questions

The set of questions relating to the topic of Pharmaceutical Antitrust and answered by the guide for each jurisdiction covered include:

  1. What is the applicable regulatory framework for the authorisation, pricing and marketing of pharmaceutical products, including generic drugs?

  2. Which authorities are entrusted with enforcing these rules?

  3. Are drug prices subject to regulatory control?

  4. Is the distribution of pharmaceutical products subject to a specific framework or legislation? Do the rules differ depending on the distribution channel?

  5. Which aspects of the regulatory framework are most directly relevant to the application of competition law to the pharmaceutical sector?

  6. What are the main competition law provisions and which authorities are responsible for enforcing them?

  7. What actions can competition authorities take to tackle anticompetitive conduct or agreements in the pharmaceutical sector and what remed